Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Bio-Techne Corp. (TECH) PT Raised to $560 at Stifel
August 5, 2021 3:56 PM EDTStifel analyst Daniel Arias raised the price target on Bio-Techne Corp. (NASDAQ: TECH) to $560.00 (from $475.00) while maintaining a Buy rating.
The analyst commented, "Bio-Techne posted another strong quarter on the heels of the lab spending rebound and demand for a portfolio that... More
Bio-Techne (TECH) Tops Q4 EPS by 17c
August 5, 2021 6:52 AM EDTBio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.87, $0.17 better than the analyst estimate of $1.70. Revenue for the quarter came in at $259 million versus the consensus estimate of $244.62 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... More